Cargando…

Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol

BACKGROUND: Despite pre-kidney-transplant cardiovascular (CV) assessment being routine care to minimise perioperative risk, the utility of such assessment is not well established. The study reviewed the evaluation and outcome of a standardised CV assessment protocol. METHODS: Data were analysed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramphul, Robin, Fernandez, Maria, Firoozi, Sam, Kaski, Juan C., Sharma, Rajan, Banerjee, Debasish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759801/
https://www.ncbi.nlm.nih.gov/pubmed/29310598
http://dx.doi.org/10.1186/s12882-017-0795-z
_version_ 1783291272090353664
author Ramphul, Robin
Fernandez, Maria
Firoozi, Sam
Kaski, Juan C.
Sharma, Rajan
Banerjee, Debasish
author_facet Ramphul, Robin
Fernandez, Maria
Firoozi, Sam
Kaski, Juan C.
Sharma, Rajan
Banerjee, Debasish
author_sort Ramphul, Robin
collection PubMed
description BACKGROUND: Despite pre-kidney-transplant cardiovascular (CV) assessment being routine care to minimise perioperative risk, the utility of such assessment is not well established. The study reviewed the evaluation and outcome of a standardised CV assessment protocol. METHODS: Data were analysed for 231 patients (age 53.4 ± 12.9 years, diabetes 34.6%) referred for kidney transplantation between 1/2/2012-31/12/2014. One hundred forty-three patients were high-risk (age > 60 years, diabetes, CV disease, heart failure, peripheral vascular disease) and offered dobutamine stress echocardiography (DSE); 88 patients were low-risk and offered ECG and echocardiography with/without exercise treadmill test. RESULTS: At the end of follow-up (579 ± 289 days), 35 patients underwent kidney transplantation and 50 were active on the waitlist. There were 24 events (CV or death), none were perioperative. One hundred fifteen patients had DSE with proportionally more events in DSE-positive compared to DSE-negative patients (6/34 vs. 7/81, p = 0.164). In 42 patients who underwent coronary angiography due to a positive DSE or ischaemic heart disease symptoms, 13 (31%) had events, 6 were suspended, 11 removed from waitlist, 3 wait-listed, 1 transplanted and 17 still undergoing assessment. Patients with significant coronary artery disease requiring intervention had poorer event-free survival compared to those without intervention (56% vs. 83% at 2 years, p = 0.044). However, the association became non-significant after correction for CV risk factors (HR = 3.17, 95% CI 0.51–19.59, p = 0.215). CONCLUSIONS: The stratified CV risk assessment protocol using DSE in all high-risk patients was effective in identifying patients with coronary artery disease. The coronary angiograms identified the event-prone patients effectively but coronary interventions were not associated with improved survival.
format Online
Article
Text
id pubmed-5759801
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57598012018-01-16 Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol Ramphul, Robin Fernandez, Maria Firoozi, Sam Kaski, Juan C. Sharma, Rajan Banerjee, Debasish BMC Nephrol Research Article BACKGROUND: Despite pre-kidney-transplant cardiovascular (CV) assessment being routine care to minimise perioperative risk, the utility of such assessment is not well established. The study reviewed the evaluation and outcome of a standardised CV assessment protocol. METHODS: Data were analysed for 231 patients (age 53.4 ± 12.9 years, diabetes 34.6%) referred for kidney transplantation between 1/2/2012-31/12/2014. One hundred forty-three patients were high-risk (age > 60 years, diabetes, CV disease, heart failure, peripheral vascular disease) and offered dobutamine stress echocardiography (DSE); 88 patients were low-risk and offered ECG and echocardiography with/without exercise treadmill test. RESULTS: At the end of follow-up (579 ± 289 days), 35 patients underwent kidney transplantation and 50 were active on the waitlist. There were 24 events (CV or death), none were perioperative. One hundred fifteen patients had DSE with proportionally more events in DSE-positive compared to DSE-negative patients (6/34 vs. 7/81, p = 0.164). In 42 patients who underwent coronary angiography due to a positive DSE or ischaemic heart disease symptoms, 13 (31%) had events, 6 were suspended, 11 removed from waitlist, 3 wait-listed, 1 transplanted and 17 still undergoing assessment. Patients with significant coronary artery disease requiring intervention had poorer event-free survival compared to those without intervention (56% vs. 83% at 2 years, p = 0.044). However, the association became non-significant after correction for CV risk factors (HR = 3.17, 95% CI 0.51–19.59, p = 0.215). CONCLUSIONS: The stratified CV risk assessment protocol using DSE in all high-risk patients was effective in identifying patients with coronary artery disease. The coronary angiograms identified the event-prone patients effectively but coronary interventions were not associated with improved survival. BioMed Central 2018-01-08 /pmc/articles/PMC5759801/ /pubmed/29310598 http://dx.doi.org/10.1186/s12882-017-0795-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ramphul, Robin
Fernandez, Maria
Firoozi, Sam
Kaski, Juan C.
Sharma, Rajan
Banerjee, Debasish
Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title_full Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title_fullStr Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title_full_unstemmed Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title_short Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
title_sort assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759801/
https://www.ncbi.nlm.nih.gov/pubmed/29310598
http://dx.doi.org/10.1186/s12882-017-0795-z
work_keys_str_mv AT ramphulrobin assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol
AT fernandezmaria assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol
AT firoozisam assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol
AT kaskijuanc assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol
AT sharmarajan assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol
AT banerjeedebasish assessingcardiovascularriskinchronickidneydiseasepatientspriortokidneytransplantationclinicalusefulnessofastandardisedcardiovascularassessmentprotocol